American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and …
K Cusi, S Isaacs, D Barb, R Basu, S Caprio… - Endocrine Practice, 2022 - Elsevier
Objective To provide evidence-based recommendations regarding the diagnosis and
management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …
management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …
Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD
Hepatic steatosis is a key histological feature of nonalcoholic fatty liver disease (NAFLD).
The non-invasive quantification of liver fat is now possible due to advances in imaging …
The non-invasive quantification of liver fat is now possible due to advances in imaging …
AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
Chronic liver disease (CLD) is associated with approximately two million annual deaths
worldwide and is an enormous health burden.[1, 2] The majority of liver-related outcomes …
worldwide and is an enormous health burden.[1, 2] The majority of liver-related outcomes …
NAFLD in children: new genes, new diagnostic modalities and new drugs
Nonalcoholic fatty liver disease (NAFLD) has rapidly become the most common form of
chronic liver disease in children and adolescents. Over the past 5 years, developments have …
chronic liver disease in children and adolescents. Over the past 5 years, developments have …
Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non‐alcoholic fatty liver disease assessed by …
A Flint, G Andersen, P Hockings… - Alimentary …, 2021 - Wiley Online Library
Background Glucagon‐like peptide‐1 receptor agonists may be a treatment option in
patients with non‐alcoholic fatty liver disease (NAFLD). Aims To investigate the effects of …
patients with non‐alcoholic fatty liver disease (NAFLD). Aims To investigate the effects of …
Change in MRI-PDFF and histologic response in patients with nonalcoholic steatohepatitis: a systematic review and meta-analysis
JG Stine, N Munaganuru, A Barnard, JL Wang… - Clinical …, 2021 - Elsevier
Background & Aims Magnetic resonance imaging proton density fat fraction (MRI-PDFF)
offers promise as a non-invasive biomarker of treatment response in early-phase …
offers promise as a non-invasive biomarker of treatment response in early-phase …
Effect of a low free sugar diet vs usual diet on nonalcoholic fatty liver disease in adolescent boys: a randomized clinical trial
JB Schwimmer, P Ugalde-Nicalo, JA Welsh… - Jama, 2019 - jamanetwork.com
Importance Pediatric guidelines for the management of nonalcoholic fatty liver disease
(NAFLD) recommend a healthy diet as treatment. Reduction of sugary foods and beverages …
(NAFLD) recommend a healthy diet as treatment. Reduction of sugary foods and beverages …
Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis
J Gu, S Liu, S Du, Q Zhang, J **ao, Q Dong, Y **n - European radiology, 2019 - Springer
Objective To systematically review studies about the diagnostic accuracy of magnetic
resonance imaging proton density fat fraction (MRI-PDFF) in the classification of hepatic …
resonance imaging proton density fat fraction (MRI-PDFF) in the classification of hepatic …
Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis
Background Lipid accumulation product (LAP) is an index calculated by waist circumference
(WC) and triglyceride (TG), which reflects lipid toxicity. This study aims to investigate the …
(WC) and triglyceride (TG), which reflects lipid toxicity. This study aims to investigate the …
[HTML][HTML] Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: analysis of data from a phase II trial of …
S Jayakumar, MS Middleton, EJ Lawitz, PS Mantry… - Journal of …, 2019 - Elsevier
Background & Aims Non-invasive tools for monitoring treatment response and disease
progression in non-alcoholic steatohepatitis (NASH) are needed. Our objective was to …
progression in non-alcoholic steatohepatitis (NASH) are needed. Our objective was to …